<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sixteen unselected untreated patients with primary <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and various combinations of blood cytopenia were treated with <z:chebi fb="1" ids="4315">danazol</z:chebi>, an attenuated <z:chebi fb="3" ids="50113">androgen</z:chebi> reported to be of some value in these conditions </plain></SENT>
<SENT sid="1" pm="."><plain>After a 12 week trial (<z:chebi fb="1" ids="4315">danazol</z:chebi> 600 mg/day/p.o.), <z:hpo ids='HP_0001903'>anaemia</z:hpo> improved in 4/14 patients, with transfusional requirements being reduced by 50% or more in four other cases (response 57%) </plain></SENT>
<SENT sid="2" pm="."><plain>An enhanced reticulocyte production was documented in 6/13 cases (46%), and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> resolved in 5/8 (62%) </plain></SENT>
<SENT sid="3" pm="."><plain>Results of the granulocyte count were less satisfactory, with only one partial response obtained among five cases </plain></SENT>
<SENT sid="4" pm="."><plain>A normalization of the monocyte count was seen in 3/5 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath>, with one of them achieving a complete haematological and clinical remission lasting 6 months </plain></SENT>
<SENT sid="5" pm="."><plain>Circulating blast cells decreased significantly (50% or more) in 4/6 cases </plain></SENT>
<SENT sid="6" pm="."><plain>Although clinical symptoms from <z:hpo ids='HP_0001903'>anaemia</z:hpo> and <z:mp ids='MP_0001914'>bleeding</z:mp> disappeared in responsive cases, four patients developed <z:hpo ids='HP_0011009'>acute</z:hpo> non-lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="1" ids="4315">Danazol</z:chebi> was well tolerated and produced no <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> toxicity </plain></SENT>
<SENT sid="8" pm="."><plain>The drug appears useful in the management of anaemic and thrombocytopenic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
</text></document>